Table 2 Comparison of patients with and without biochemical recurrence
Recurrence-free n = 315 | Biochemical Recurrence n = 138 | |
|---|---|---|
Preoperative data | ||
Age – median (IQR) | 63.0 (58.0–68.0) | 64.0 (59.0–69.0) |
Preoperative PSA – median (IQR) | 6.0 (4.5–8.0) | 8.0 (5.9–10.9) |
Pathological results | ||
Pathological Gleason Score | ||
≤6 | 150 (48%) | 21 (15%) |
3 + 4 | 113 (36%) | 46 (33%) |
4 + 3 | 33 (10%) | 31 (22%) |
> 8 | 19 (6%) | 36 (26%) |
unknown | 0 (0%) | 3 (2%) |
pT stage | ||
pT2 | 259 (82%) | 62 (45%) |
pT3a | 40 (13%) | 35 (25%) |
pT3b | 16 (5%) | 36 (26%) |
pT4 | 0 (0%) | 2 (1%) |
unkwon | 0 (0%) | 3 (2%) |
Involvment of lymph nodes | 2 (1%) | 10 (7%) |
Positive surgical margins | ||
Apical | ||
focal | 29 (9%) | 14 (10%) |
extensive | 6 (2%) | 13 (9%) |
Posterolateral | ||
focal | 18 (6%) | 21 (15%) |
extensive | 7 (2%) | 11 (8%) |
Base | ||
focal | 11 (3%) | 11 (8%) |
extensive | 4 (1%) | 3 (2%) |
Bladder neck | ||
focal | 1 (0%) | 1 (1%) |
extensive | 0 (0%) | 0 (0%) |